Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease Grant

Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer's Disease .

date/time interval

  • November 2, 2021 - November 1, 2028

awarded by

administered by

sponsor award ID

  • Award Recognition - NCT03671889
  • NCT03671889

contributor